(Reuters) - Pfizer Inc's (N:PFE) quarterly revenue rose about 11 percent, driven by sales of newer drugs and the acquisition of hospital products company Hospira last year.
The largest U.S. drugmaker's revenue rose to $13.15 billion in the second quarter from $11.85 billion, a year earlier.
The company's net income fell to $2.02 billion, or 33 cents per share, from $2.63 billion, or 42 cents per share.
Pfizer in April terminated its $160 billion tax inversion deal to acquire Irish drugmaker Allergan Plc (N:AGN).